Cat. No. | Product name | CAS No. |
DC22449 |
PD-146176
A potent, selective, non-competitve inhibitor of 15-lipoxygenase (15-LOX) with Ki of 197 nM. |
4079-26-9 |
DC22447 |
FAAH-IN-2
A potent, selective, noncovalent FAAH inhibitor with IC50 of 28 nM toward human FAAH and 100 nM toward rat FAAH. |
1361993-03-4 |
DC22680 |
Conivaptan
A potent, selective, nonpeptide vasopressin V1A and V2 receptor antagonist with Ki of 0.48 nM and 3.04 nM respectively. |
210101-16-9 |
DC21738 |
TBC3486
A potent, selective, non-peptidic integrin α4β1 (VLA-4) antagonist with IC50 of 9 nM, displays 200-fold selectivity over α4β7 (IC50=2.1 uM). |
247044-77-5 |
DC20617 |
AA-CW236
Featured
A potent, selective, non-pseudosubstrate inhibitor of O(6) -alkylguanine DNA methyltransferase (MGMT) with low-nanomolar potency. |
1869921-96-9 |
DC21593 |
RUC-4
Featured
A potent, selective, non-RGD-mimetic αIIbβ3 integrin receptor antagonist with IC50 of 45 nM, with no activity on αVβ3 receptors. . |
1448313-27-6 |
DC23596 |
Luseogliflozin
A potent, selective, orally acitve SGLT2 inhibitor with IC50 of 2.26 nM, 1650-fold selectivity over SGLT1. |
898537-18-3 |
DC21307 |
MKC-733
A potent, selective, orally active 5-HT3 receptor agonist with high affinity for canine intestinal smooth muscle 5-HT3 receptors. |
194093-42-0 |
DC21606 |
SB-357134
A potent, selective, orally active and CNS penetrant 5-HT6 receptor antagonist with pKi of 8.5, displays 1300-fold selectivity over other 13 5-HT receptor subtypes. |
219963-52-7 |
DC20774 |
VTP 37948
A potent, selective, orally active BACE1 inhibitor for the treatment of Alzheimer's disease.. |
|
DC20665 |
AMG 8718
A potent, selective, orally active BACE1 inhibitor with IC50 of 0.7 nM, demonstrates limited selectivity for over BACE2 and high selectivity both renin and pepsin. |
1215868-94-2 |
DC20324 |
BRS-3 agonist Compound A
A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist with EC50 of 250/100 nM for human/rat BRS-3, resp+H1437+M1438. |
|
DC20325 |
BRS-3 agonist Compound A racemate
A potent, selective, orally active bombesin receptor subtype-3 (BRS-3) agonist with EC50 of 270/130 nM for human/rat BRS-3, respectively. |
|
DC21187 |
JTE907
Featured
A potent, selective, orally active cannabinoid CB2 receptor inverse agonist with Ki of 35.9, 1.55 and 0.38 nM for human, mouse and rat CB2, respectively. |
282089-49-0 |
DC21793 |
VER-250840
A potent, selective, orally active Chk1 inhibitor with IC50 of < 1 nM, Ki=69 pM. |
|
DC22898 |
L-365260
A potent, selective, orally active cholecystokinin receptor 2 (CCK2) antagonist with IC50 of 2 nM. |
118101-09-0 |
DC22485 |
Gefitinib hydrochloride
Featured
A potent, selective, orally active EGFR inhibitor with IC50 of 23 nM. |
184475-55-6 |
DC21443 |
ONO-5334
A potent, selective, orally active inhibitor of cathepsin K with Ki of 0.1 nM, 0.049 nM and 0.85 nM for human, rabbit and rat cathepsin K, respectively. |
868273-90-9 |
DC23340 |
CCT-251455
A potent, selective, orally active monopolar spindle 1 (MPS1) inhibitor with IC50 of 3 nM, with no activity for CDK2 and Aurora A (IC50>40 uM). |
1400284-80-1 |
DC25200 |
PF-1355
Featured
PF-1355 is a potent, selective, orally active Myeloperoxidase (MPO) inhibitor with EC50 of 1.47 uM. |
1435467-38-1 |
DC22900 |
MLE-4901
Featured
A potent, selective, orally active neurokinin 3 (NK3R) antagonist for the treatment of schizophrenia. |
941690-55-7 |
DC22664 |
Fezolinetant
Featured
Fezolinetant is an antagonist of the neurokinin 3 receptor (NK3R), used for the treatment of menopausal hot flushes. |
1629229-37-3 |
DC22686 |
SCH 221510
A potent, selective, orally active nociceptin opioid receptor (NOP) agonist with EC50 of 12 nM, Ki of 0.3 nM. |
322473-89-2 |
DC21276 |
Seltorexant
A potent, selective, orally active orexin-2 receptor (OX2R) antagonist with pKi of 8.0 and 8.1 for human and rat OX2R, respectively. |
1293281-49-8 |
DC21148 |
IPI-443
A potent, selective, orally active p110δ/γ PI3K dual inhibitor with cellular IC50 of 0.29 and 7.1 nM, respectively. |
|
DC20681 |
AS1940477
A potent, selective, orally active p38α/p38β inhibitor with IC50 of 11.2/36.5 nM respectively, with no effect on p38γ and δ isoforms (IC50>1 uM). |
928344-12-1 |
DC23441 |
CS-0777
A potent, selective, orally active S1P receptor-1 (S1P1) agonist with EC50 of 1.1 nM, 320-fold selectivity over S1P3. |
827344-05-8 |
DC25065 |
NIBR 0213
Featured
A potent, selective, orally active S1P1 antagonist with IC50 of 2.5 nM Ca2+ mobilization assays, without activity on S1P2, S1P3 and S1P4 (IC50>10 uM). |
1233332-14-3 |
DC21287 |
MK-4256
A potent, selective, orally active somatostatin receptor SSTR3 antagonist with binding Ki of 0.66 nM, >500-fold selectivity over SSTR1/2/4/5. |
1104599-69-0 |
DC21295 |
MK-1421
A potent, selective, orally active somatostatin receptor SSTR3 antagonist with binding Ki of 2.3 nM, >2,500-fold selectivity over SSTR1/2/4/5 (IC50>5 uM). |
1235995-16-0 |
DC21579 |
RO 5073012
A potent, selective, orally active TAAR1 partial agonist with Ki of 6 nM, EC50 of 23 nM (hTAAR1), 140-fold selectivity over β2 adrenergic receptors. |
1020814-70-3 |
DC20654 |
AM-0902
Featured
A potent, selective, orally active TRPA1 channel antagonist with IC50 of 71 and 131 nM for rTRPA1 and hTRPA1 in Ca2+ flux assays respectively, without agonist activity (EC50>40 uM). |
1883711-97-4 |
DC21179 |
JNJ 41876666
A potent, selective, orally active TRPM8 channel antaognist with IC50 of 0.8 nM, . |
1259026-14-6 |
DC23198 |
Adomeglivant
A potent, selective, orally active, small-molecule antagonist of human glucagon receptor with Ki of 6.66 nM. |
1488363-78-5 |
DC22681 |
E 6130
A potent, selective, orally available CX3C chemokine receptor 1 (CX3CR1) modulator that inhibits the fractalkine-induced chemotaxis of human peripheral blood NK cells with IC50 of 4.9 nM. |
1427058-33-0 |
DC23581 |
TASP0315003
A potent, selective, orally available GlyT1 inhibitor with IC50 of 1.6 nM, weakly inhibits rat GlyT2 (IC50=138 nM). |
1007109-16-1 |
DC23611 |
DCCCyB
A potent, selective, orally available GlyT1 inhibitor with IC50 of 29 nM, demonstrates excellent in vivo occupancy of GlyT1 transporters in vivo.. |
1236046-15-3 |
DC23599 |
PF-0346275
Featured
PF-0346275 is a potent, selective, orally available GlyT1 inhibitor with Ki of 11.6 nM, without activity against GlyT2 (IC50>10 uM). |
1173239-39-8 |
DC23486 |
DS-1558
A potent, selective, orally available GPR40 agonist with EC50 of 3.7 nM. |
1202575-67-4 |
DC23300 |
T-3256336
A potent, selective, orally available IAP antagonist with IC50 of 1.3, 2.2 and 200 nM for cIAP-1, cIAP-2 and XIAP, respectively. |
1266227-69-3 |
DC24182 |
Nilotinib monohydrochloride monohydrate
Featured
A potent, selective, orally available inhibitor of both native and mutant Bcr-Abl with IC50 of 20-80 nM. |
923288-90-8 |
DC23925 |
Vaniprevir
A potent, selective, orally available inhibitor of HCV NS3/4A protease with Ki of 0.05 and 0.9 nM for GT1b and 2a protease, respectively. |
923590-37-8 |
DC23358 |
CD 161
A potent, selective, orally bioavailable BET bromodomain inhibitor with IC50 of 7.2 and 28.2 nM for BRD4 BD2 and BRD4 BD1, respectively. |
1627716-22-6 |
DC21177 |
JNJ 39758979
Featured
JNJ-39758979 is a selective, orally active, and high-affinity histamine H4 receptor antagonist with Kis of 12.5, 5.3, and 25 nM for human, mouse, and monkey histamine H4 receptor, respectively. JNJ-39758979 functionally antagonizes histamine-induced cAMP inhibition with a pA2 of 7.9 in transfected cells. JNJ-39758979 shows good anti-inflammatory and antipruritic activity. |
1046447-90-8 |
DC24048 |
NVP-BKM120 hydrochloride
Featured
A potent, selective, orally bioavailable inhibitor of class I PI3K isoforms with IC50 of 52 nM/166 nM/116 nM/262 nM for p110α/β/δ/γ, respectively. |
1312445-63-8 |
DC22882 |
KRH-3955
A potent, selective, orally bioavailable inhibitor of CXCR4 that efficiently inhibits SDF-1α binding to CXCR4 with IC50 of 0.61 nM. |
1097732-62-1 |
DC24065 |
EPZ-011989 trifluoroacetate
A potent, selective, orally bioavailable inhibitor of EZH2 with Ki of < 3 nM. |
1598383-41-5 |
DC23552 |
AS-2444697 HCl
Featured
A potent, selective, orally bioavailable IRAK-4 inhibitor that potently inhibits human and rat IRAK-4 activity with subnanomolar order, >30-fold selectivity over IRAK-1. |
1287665-60-4 |
DC22941 |
AZD-9056
A potent, selective, orally bioavailable P2X7 receptor antagonist. |
345304-65-6 |
DC21607 |
SB-649868
Featured
SB-649868 is a potent and selective orally active orexin (OX) 1 and OX2 receptor antagonist (pKi =9.4 and 9.5 at the OX1 and OX2 receptor, respectively). |
380899-24-1 |
DC21598 |
RWJ-56110
A potent, selective, peptide-mimetic PAR-1 antagonist with binding IC50 of 0.44 uM, with no effect on PAR-2, PAR-3, or PAR-4. |
252889-88-6 |
DC20691 |
ASP 3652
A potent, selective, peripherally active and orally available FAAH inhibitor for treatment of chronic prostatitis/chronic pelvic pain syndrome.. |
|
DC23043 |
Tpl2-IN-2p
A potent, selective, reversible and ATP-competitive inhibitor of Tpl2 kinase with IC50 of 50 nM. |
871307-18-5 |
DC23933 |
MK-0893
A potent, selective, reversible and competitive antagonist of glucagon receptor with high binding affinity (IC(=50=6.6 nM) and functional cAMP activity (IC50=15.7 nM). |
870823-12-4 |
DC20412 |
II-B08
A potent, selective, reversible inhibitor of PTP SHP2 with IC50 of 5.5 uM, exhibits >3-fold selectivity for SHP2 over other PTPs. |
1143579-78-5 |
DC11875 |
GlpG inhibitor 11
A potent, selective, reversible rhomboid proteases inhibitor with Ki of 45 nM for GlpG . |
|
DC22892 |
KNT-127
A potent, selectove δ-opioid receptor agonist with Ki of 0.16 nM, dispalys 133.5-fold and 960.5-fold selectivity over μOR and κOR respectively. |
1256921-89-7 |
DC22563 |
TN1
A potent, small molecule fetal hemoglobin (HbF) inducer with EC50 of 100 nM. |
289479-94-3 |
DC20606 |
8-Thioquinoline
A potent, small molecule inhibitor of the proteasome subunit Rpn11 with IC50 of 2.5 uM.. |
491-33-8 |
DC21321 |
ML349
Featured
A potent, specific acyl protein thioesterase 2 (APT-2, LYPLA2) inhibitor with IC50 of 144 nM and Ki of 120 nM, >20-fold selectivity over APT-1 and serine hydrolase enzyme family. |
890819-86-0 |
DC22529 |
FPTQ
A potent, specific and allosteric mGluR1 antagonist with IC50 of 6 nM and 1.4 nM for human and mouse mGluR1, respectively.. |
864863-72-9 |
DC25075 |
Sivelestat sodium
A potent, specific and competitive inhibitor of human neutrophil elastase with IC50 of 44 nM. |
150374-95-1 |
DC23074 |
Sivelestat
A potent, specific and competitive inhibitor of human neutrophil elastase with IC50 of 44 nM. |
127373-66-4 |
DC23494 |
GRI 977143
Featured
A potent, specific and nonlipid agonist of LPA2 receptor with EC50 of 3.3 uM, does not activate any of the other LPA GPCRs (>10 uM). |
325850-81-5 |
DC24105 |
MK-0591(Quiflapon )
Featured
A potent, specific and orally active 5-Lipoxygenase-activating protein (FLAP) inhibitor with IC50 of 1.6 nM in FLAP binding assay. |
136668-42-3 |
DC11556 |
trans-AUCB
A potent, specific and orally bioavailable soluble epoxide hydrolase (sEH) inhibitor with IC50 of 1.3 nM. |
885012-33-9 |
DC21802 |
VU 0364849
A potent, specific BMP receptor activin receptor-like kinase 3 (ALK3) antaognist with Ki of 5.4 nM. |
1206711-14-9 |
DC21807 |
VU 0465350
Featured
VU 0465350 is a potent, specific BMP receptor activin receptor-like kinase 3 (ALK3) antaognist with Ki of 92.3 nM; shows no activity for ALK2/4/5, also shows affinity for TGFBR2, VEGFR2 and AMPK; blocks SMAD phosphorylation in vitro and in vivo, and enhances liver regeneration after partial hepatectomy. |
1414843-61-0 |
DC21693 |
SRI-29329
A potent, specific CDC-like kinase (CLK) inhibitor with IC50 of 78, 16 and 86 nM for CLK1, 2 and4, respectively. |
2086809-58-5 |
DC21794 |
VH 298
Featured
A potent, specific cell-active VHL E3 ubiquitin ligase inhibitor that inhibits VHL/HIF-α interaction with Kd of 90 nM in ITC assays. |
2097381-85-4 |
DC23985 |
CHIR-99021 trihydrochloride
A potent, specific GSK-3 inhibitor with IC50 of 5 nM and 10 nM for GSK3β and GSK3α, respectively. |
1782235-14-6 |
DC21150 |
PR-924
A potent, specific immunoproteasome LMP7 subunit inhibitor with IC50 of 25 nM, >100-fold selectivity over β5c, β1i, β1c, β2i and β2c subunits (IC50>3 uM). |
1416709-79-9 |
DC21773 |
UK-101
A potent, specific immunoproteasome β1i (LMP2) subunit inhibitor with IC50 of 104 nM, 144- and 10-fold selectivity over β1c and β5 subunit respectivey. |
1000313-40-5 |
DC21527 |
PR-893
A potent, specific immunoproteasome β5 subunit inhibitor with IC50 of 17 nM, 21-fold and 13-fold selectivity for β5 over LMP7 and LMP2 subunits, respecitvely.. |
1426305-23-8 |
DC21365 |
NC-005
A potent, specific immunoproteasome β5 subunit inhibitor with IC50 of 44 nM, 105 and 225-fold selectivity over β2i and β1i subunit, respecitvely. |
1237540-74-7 |
DC21528 |
PR-825
A potent, specific immunoproteasome β5 subunit inhibitor.. |
935888-08-7 |
DC24007 |
R-1479
Featured
A potent, specific inhibitor of HCV NS5B polymerase and HCV replication (IC50=1.28 uM, replicon assay). |
478182-28-4 |
DC22758 |
SI-113
A potent, specific inhibitor of the SGK1 kinase activity, induces autophagy, apoptosis and ER stress in cancer cells. |
1392816-46-4 |
DC20998 |
ES 936
A potent, specific mechanism-based human NAD(P)H: quinone oxidoreductase 1 (NQO1) inhibitor that demonstrates efficient inactivation of NQO1 at 100 nM in in cellular systems. |
192820-78-3 |
DC22823 |
Tariquidar methanesulfonate hydrate
A potent, specific P-gp inhibitor with Kd of 5.1 nM. |
625375-83-9 |
DC21849 |
YU-101
A potent, specific proteasome β5 subunit inhibitor with IC50 of 0.26 uM, 7.3 and 17.3-fold selectivity over β2i and β1i subunit, respecitvely.. |
254888-42-1 |
DC26068 |
BMS-753
A potent, specific RARα agonist with Ki of 2 nM, displays no significant effects on RARγ in reporter based assays.. |
215307-86-1 |
DC22661 |
AB1
A potent, specific S1P2 receptor (Edg-5) antagonist with IC50 of 3 nM, with no agonistic or antagonistic activities on other S1PRs. |
1463912-49-3 |
DC24060 |
YM-155 hydrochloride
Featured
A potent, specific survivin inhibitor that inhibits survivin promoter activity with IC50 of 0.54 nM. |
355406-09-6 |
DC22864 |
KSP-IA
A potent, specific, allosteric and cell-active inhibitor of KSP with IC50 of 11 nM. |
639074-49-0 |
DC22865 |
CK-0106023
Featured
A potent, specific, allosteric inhibitor of KSP motor domain ATPase with Ki of 12 nM. |
336115-72-1 |
DC21318 |
ML 171
A potent, specific, cell-active NADPH oxidase1 (Nox1) inhibitor that strongly blocks ROS generation in HT29 cells with IC50 of 0.129 uM. |
6631-94-3 |
DC20890 |
ChoK-α inhibitor CK37
Featured
A potent, specific, competitive inhibitor of choline kinase-α (Chok-α) by targeting the choline binding site; significantly increases LC3II expression in MCF-7 and MCF-7/TAM cells, increases the size and number of autophagosome, causes MCF-7 and MCF-7/TAM |
1001478-90-5 |
DC21110 |
HCI-2389
A potent, specific, irreversible NIMA-related Kinase 2 (NEK2) inhibitor with IC50 of 16.65 nM. |
|
DC26079 |
GW 803430
Featured
A potent, specific, orally active melanin concentrating hormone receptor 1 (MCHR1) inhibitor with kI of 3.8 nM, >100-fold selectivity over a battery of GPCRs, ion channels and enzymes. |
515141-51-2 |
DC20928 |
CRT0066101
Featured
A potent, specific, orally active pan-PKD (protein kinase D) inhibitor with biochemical IC50 of 1, 2.5 and 2 nM for PKD1, 2, and 3 respectively. |
1883545-60-5 |
DC22550 |
TAK-220
A potent, specific, orally bioavailable CCR5 antagonist that blocks the binding of MIP-1α to CCR5 with IC50 of 1.4 nM. |
333994-00-6 |
DC22540 |
Pasireotide
Featured
Pasireotide (SOM230), a long-acting cyclohexapeptide somatostatin analogue, can improve agonist activity at somatostatin receptors (subtypes sst1/2/3/4/5, pKi=8.2/9.0/9.1/<7.0/9.9, respectively). Pasireotide can suppress GH, IGF-I and ACTH secretion, indicating potential efficacy in acromegaly and Cushing's disease. Pasireotide also exhibits antisecretory, antiproliferative, and proapoptotic activity. At equivalent molar concentrations, both the salt and free forms of a compound exhibit comparable biological activity. Nevertheless, the salt form (Pasireotide acetate) usually boasts enhanced water solubility and stability. |
396091-73-9 |
DC22539 |
Pasireotide L-aspartate salt
A potent, stable cyclohexapeptide somatostatin mimic that exhibits unique high-affinity binding to human somatostatin receptors (pKi=8.2/9.0/9.1/<7.0/9.9 for sst1/2/3/4/5, respectively). |
396091-77-3 |
DC22746 |
TROX-1
A potent, state-dependent blocker of Cav2 channels that preferentially inhibits potassium-triggered calcium influx through recombinant Cav2.2 under depolarized conditions with IC50 of 0.27 uM, compared with hyperpolarized conditions (IC50>20 uM). |
1309601-26-0 |
DC23782 |
4-Br-BnIm
A potent, subtype-selective Grp94 inhibitor with Kd of 0.96 uM, 13-fold selectivity over Hsp90α. |
1654775-71-9 |
DC23519 |
PF-06462894
A potent, subtype-selective mGluR5 negative allosteric modulator with Ki of 6.1 nM. |
1622291-66-0 |
DC22939 |
NS3861 fumarate
Featured
NS3861 fumarate is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively. |
216853-60-0 |
DC22923 |
HXJ 42
A PP1 analog that has greater selectivity and potency for Zap-70(AS) over wild-type Zap-70, as assessed by Erk and Lat phosphorylation, as well as by proliferative responses of mature CD4+ cells. |
1428640-39-4 |
DC22471 |
Pantoprazole sodium hydrate
A proton pump inhibitor that inhibits gastric acid secretion. |
164579-32-2 |
DC23928 |
Esomeprazole magnesium salt
A proton pump inhibitor that reduces stomach acid secretion by inhibition of the H+/K+-ATPase in the parietal cells. |
1198768-91-0 |
DC25089 |
Esomeprazole agnesium trihydrate
A proton pump inhibitor that reduces stomach acid secretion by inhibition of the H+/K+-ATPase in the parietal cells. |
217087-09-7 |
DC24176 |
Esomeprazole potassium salt
A proton pump inhibitor that reduces stomach acid secretion by inhibition of the H+/K+-ATPase in the parietal cells. |
161796-84-5 |
DC23938 |
Esomeprazole sodium
Featured
A proton pump inhibitor that reduces stomach acid secretion by inhibition of the H+/K+-ATPase in the parietal cells. |
161796-78-7 |
DC23004 |
PSMA-ligand-1
Featured
A PSMA (prostate-specific membrane antigen) ligand-tubulysin compound.. |
1610413-97-2 |
DC20605 |
Enexasogaol
A pungent agent isolated from Zingiber officinale Roscoe, has been known to have anti-tumor and anti-inflammatory effects. |
23513-13-5 |
DC22348 |
Zalcitabine
Featured
A pyrimidine analog reverse transcriptase inhibitor (NRTI) for the treatment of HIV/AIDS. |
7481-89-2 |
DC22388 |
Mefloquine hydrochloride
A quinoline antimalarial drug that is structurally related to the antiarrhythmic agent quinidine. |
51773-92-3 |
DC21407 |
AG-1295
A quinoxaline-type tyrphostin that acts as a potent and selective inhibitor of PDGFR kinase in vitro and in Swiss 3T3 cells with IC50 of 0.3-1 uM. |
71897-07-9 |
DC23472 |
TASP0434299
A radioligand candidate for arginine vasopressin 1B (V1B) receptor that exhibits high binding affinities for human and rat V1B receptors with IC50 of 0.526 and 0.641 nM, respectively. |
1520893-08-6 |
DC26104 |
UVI 2008
A RARβ/γ agonist originated from TTNPB, is also a selective inhibitor of aldo-keto reductase family member 1B10 (AKR1B10) with IC50 of 6.1 uM. |
1504556-86-8 |
DC22985 |
BMS-948
A RARβ-selective agonist that exhibits a full transcriptional agonistic activity and activating RARβ as efficiently as the reference agonist TTNPB. |
168901-49-3 |
DC7350 |
9-methyladenine
A receptor adenine derivative binding membrane brain animal cell line.For the detailed information of 9-methyladenine, the solubility of 9-methyladenine in water, the solubility of 9-methyladenine in DMSO, the solubility of 9-methyladenine in PBS buffer, the animal experiment (test) of 9-methyladenine, the cell expriment (test) of 9-methyladenine, the in vivo, in vitro and clinical trial test of 9-methyladenine, the EC50, IC50,and Affinity of 9-methyladenine, Please contact DC Chemicals.. |
700-00-5 |
DC23842 |
L-783277
A resorcylic lactone type covalent kinase inhibitor that inhibits ALK1 with IC50 of 125 nM, also inhibits FLT3, VEGFR2, VEGFR3, MEK2 with IC50 of 1-10 nM.. |
791807-02-8 |
DC24096 |
Dabigatran ethyl ester
A reversible and selective, direct thrombin inhibitor (DTI) with Ki value of 4.5 nM. |
429658-95-7 |
DC22367 |
Bromethalin
A rodenticide that poisons the central nervous system by uncoupling mitochondrial oxidative phosphorylation, which causes a decrease in adenosine triphosphate (ATP) synthesis.. |
63333-35-7 |
DC21011 |
KP-1019 sodium salt
A ruthenium complex anticancer agent that is useful for metastatic tumors and cis-platin resistant tumors. |
|
DC20822 |
BMT-052
A second generation, orally biovailable pan-genotypic HCV NS5B polymerase inhibitor with EC50 of 1-10 nM. |
1628720-84-2 |
DC24180 |
Cetirizine
A second-generation antihistamine that acts as a selective H1 receptor antagonist. |
83881-51-0 |
DC22589 |
Eltanexor
A second-generation SINE, orally bioavailable Exportin 1 (XPO1,CRM1) inhibitor with markedly reduced brain penetration compared to selinexor (30-fold less). |
1642300-52-4 |
DC23944 |
K-7174
Featured
A selctive small molecule inhibitor of the transcription factor GATA-binding protein 2 (GATA2). |
191089-59-5 |
DC23943 |
K-7174 dihydrochloride
Featured
K-7174 dihydrochloride is a selctive small molecule inhibitor of the transcription factor GATA-binding protein 2 (GATA2). |
191089-60-8 |
DC20568 |
Tec Kinase-IN-6
A selecitve small molecule toward Tec kinase-mediated tyrosine phosphorylation of FGF2 with IC50 of 8.9 uM. |
923762-87-2 |
DC23996 |
Capadenoson
Featured
Capadenoson is a selective agonist of adenosine-A1 receptor. |
544417-40-5 |
DC22954 |
MG-624
Featured
MG624 is a potent and selective neuronal α7 nAChR antagonist with a Ki of 106 nM. |
77257-42-2 |
DC21853 |
Ogerin
Featured
A selective GPR68 positive allosteric modulator (pEC50=6.83) with minimal PAM activity at the related proton-sensing GPCRs GPR4 and GPR65. |
1309198-71-7 |
DC20596 |
O-phenanthroline
A selective inhibitor of 26S proteasome subunit Rpn11 with IC50 of 10±2 uM. |
66-71-7 |
DC22980 |
ND-336
A selective inhibitor of the gelatinases MMP2 and MMP9 and MMP13 with Ki of 85, 150 and 120 nM, respectively. |
1807453-83-3 |
DC21127 |
HT-0411
A selective monoamine oxidase B (MAO-B) inhibitor with IC50 of 1.4 uM, with less potency for MT-1 and MT-2. |
947539-81-3 |
DC23235 |
Flupirtine
A selective neuronal potassium channel (KCNQ/KV7 channel) activator that also has indirect NMDA receptor antagonist and GABAA receptor modulatory properties. |
56995-20-1 |
DC26069 |
SR-11237
Featured
SR-11237 is a selective pan retinoid X receptor (RXR) agonist with no retinoid A receptor (RAR) activity. . |
146670-40-8 |
DC22616 |
CJ-42794
Featured
A selective prostaglandin E receptor subtype 4 (EP4) antagonist with pKi of 8.5. |
847728-01-2 |
DC20567 |
Tec Kinase-IN-21
A selective small molecule toward Tec kinase-mediated tyrosine phosphorylation of FGF2 with IC50 of 11.7 uM. |
931664-41-4 |
DC20566 |
Tec Kinase-IN-14
A selective small molecule toward Tec kinase-mediated tyrosine phosphorylation of FGF2 with IC50 of 7.0 uM. |
852838-07-4 |
DC25014 |
Cysmethynil
A selective small-molecule inhibitor of tisoprenylcysteine carboxyl methyltransferase (Icmt) with IC50 <200 nM, does not inhibit other enzymes (farensyltransferase, geranylgeranyltransferase type I, and Rce1) at concentrations up to 50 uM. |
851636-83-4 |
DC22924 |
3M-002
A selective TLR8 agonist that induces activation of NF-κB at 0.4 uM. |
256922-53-9 |
DC20306 |
AMTB hydrochloride
Featured
A selective TRPM8 channel blocker with pEC50 of 6.91 in Ca(2+) influx assay, with no activity for TRPV4 (pEC50<4.6). |
926023-82-7 |
DC23226 |
Guanfacine
A selective α2A receptor agonist that can reduce peripheral sympathetic outflow and thus cansues a reduction in peripheral sympathetic tone. |
29110-47-2 |
DC24156 |
Metoprolol
A selective β1 receptor blocker used in treatment of several diseases of the cardiovascular system, especially hypertension.. |
51384-51-1 |
DC7029 |
SC-26196
Featured
A selective Δ6 desaturase inhibitor that displays selectivity over Δ5 and Δ9 desaturases |
218136-59-5 |
DC26107 |
TRV0109101 hydrochloride
A selective, G protein-biased µ-opioid receptor agonist, does not promote the development of opioid-induced mechanical allodynia (OIMA) and rapidly reverses allodynia in vivo.. |
2101210-22-2 |
DC26103 |
TRV0109101
A selective, G protein-biased µ-opioid receptor agonist, does not promote the development of opioid-induced mechanical allodynia (OIMA) and rapidly reverses allodynia in vivo.. |
1401027-29-9 |
DC21728 |
TAK-070
A selective, nonpeptidic, noncompetitive BACE1 inhibitor with IC50 of 3.15 uM in cell-free assays. |
365276-12-6 |
DC20995 |
EP009
A selective, orally active JAK3 inhibitor that reduces IL-2-mediated JAK3 tyrosine phosphorylation with cellular IC50 of 10-20 uM. |
1462951-30-9 |
DC20287 |
δ-secretase inhibitor 11
A selective, orally bioactive and brain permeable δ-secretase (AEP. |
842964-18-5 |
DC22971 |
CDE 096
A selective, reversible, high-affinity PAI-1 inhibitor that prevents PAI-1 from inactivating tPA and uPA with similar potency (IC50=30 and 25 nM, respectively). |
1228357-04-7 |
DC21780 |
UNC-3230
A selective, small molecule inhibitor of PIP5K1C with IC50 of 41 nM, does not ihibits other lipid kinases including PI3Ks. |
1031602-63-7 |
DC21400 |
NS-1209
A selective, water-soluble, in vivo long-lasting AMPA antagonist with Ki of 43 nM. |
245063-59-6 |
DC22451 |
AQX 1125 acetate
A sepecific, orally bioavailable SHIP1 activator with no effect on functional androgen, oestrogen, oestrogen-related receptor α, glucocorticoid, mineralocorticoid and progesterone receptor at 30 uM. |
782487-29-0 |
DC23981 |
BCX-1470 methanesulfonate
Featured
A serine protease inhibitor that inhibits the esterolytic activity of factor D (IC50=96 nM) and C1s (IC50=1.6 nM). |
217099-44-0 |
DC22666 |
Levosalbutamol
A short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).. |
34391-04-3 |
DC23231 |
Levalbuterol tartrate
A short-acting β2 adrenergic receptor agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).. |
661464-94-4 |
DC22828 |
DBCO-Amine
A simple DBCO-containing building block used to derivatize carboxyl groups in the presence of activators (e.g. EDC, or DCC) or activated esters (e.g. NHS esters) with DBCO moiety through a stable amide bond. |
1255942-06-3 |
DC23011 |
Shz-1
A small cardiogenic molecule that potently induces Nkx2.5 and a subset of other cardiac markers, including myocardin, troponin-I, and sarcomeric α-tropomyosin (SαTM) in a variety of different stem/progenitor cells. |
326886-05-9 |
DC25018 |
Shz-3
A small cardiogenic molecule that potently induces Nkx2.5 and a subset of other cardiac markers, including myocardin, troponin-I, and sarcomeric α-tropomyosin (SαTM) in a variety of different stem/progenitor cells. |
1033831-23-0 |
DC21818 |
MIN-117
A small molecule 5-HT1A and 5-HT2A receptor antagonist and inhibitor of serotonin and dopamine reuptake, also possess affinity for the α1A- and α1B-adrenergic receptors.. |
310392-93-9 |
DC22831 |
VU 0038882
A small molecule activator of S. aureus HssRS (heme sensor system) that induces endogenous heme biosynthesis by perturbing central metabolism. |
429653-28-1 |
DC23648 |
TKN2
A small molecule allosteric inhibitor of TREK channels with IC50 of 3.8, 1.7 and 10.3 uM for TREK-1, TREK-2 and TRAAK, respectively.. |
886636-57-3 |
DC23585 |
28NH
A small molecule allosteric inhibitor of TREK channels with IC50 of 5.0, 5.0 and 11.8 uM for TREK-1, TREK-2 and TRAAK, respectively.. |
1082816-22-5 |
DC23582 |
TKN1
A small molecule allosteric inhibitor of TREK channels with IC50 of 6.5, 4.4 and 15.7 uM for TREK-1, TREK-2 and TRAAK, respectively.. |
432533-28-3 |
DC23241 |
TAME
A small molecule anaphase-promoting complex/cyclosome (APC/C) inhibitor that binds to the APC preferentially suppresses APC/C(Cdc20) rather than APC/C(Cdh1). |
901-47-3 |
DC11655 |
ABO dihydrochloride
A small molecule ANXA7 GTPase activity inhibitor, induces mouse ESCs differentiation to VECs. |
896126-03-7 |
DC24017 |
SMER-18
A small molecule autophagy enhancer that induces autophagy independently of rapamycin in mammalian cells and enhances the clearance of autophagy substrates such as mutant huntingtin and A53T alpha-synuclein. |
944153-47-3 |
DC23190 |
LM22A-4
A small molecule BDNF mimetic that act as a direct and specific partial agonist of TrkB (EC50=200-500 pM), but not p75. |
37988-18-4 |
DC25021 |
Endosidin-2
Featured
A small molecule binds to the EXO70 (exocyst component of 70 kDa) subunit of the exocyst complex (Kd=253 uM), resulting in inhibition of exocytosis and endosomal recycling in both plant and human cells and enhancement of plant vacuolar trafficking.. |
1839524-44-5 |
DC22842 |
DMJ-I-228
A small molecule CD4-mimetic that binds gp120 and blocks CD4 binding, inhibits HIV-1 entry with IC50 of 86.9 uM.. |
1374035-59-2 |
DC22524 |
ZSET1446
A small molecule cognitive enhancer that potentiates acetylcholine-mediated facilitation of inhibitory synaptic transmission in the hippocampal neurons. |
887603-94-3 |
DC20445 |
Me6TREN
A small molecule Cu complexing ligand used for atom transfer radical polymerization (ATRP). |
33527-91-2 |
DC21067 |
TB-03
A small molecule Grb2 SH2 domain binding antagonist that synergistically enhances inhibition of K562 leukemia cell proliferation by imatinib (CI=0.774). |
491831-49-3 |
DC22843 |
DDX3-IN-16d
Featured
A small molecule inhibitor (IC50=0.3 uM) of DEAD-box polypeptide 3 (DDX3), a human host factor required for the replication of several DNA and RNA viruses. |
1919828-83-3 |
DC11645 |
Pitstop 2
Featured
A small molecule inhibitor of clathrin terminal domain and inhibits clathrin-mediated endocytosis. |
1419320-73-2 |
DC23010 |
R-59949(R-59-949)
Featured
A small molecule inhibitor of diacylglycerol kinase (DGK) with IC50 of 0.01-10 uM in isolated platelet membranes and in intact platelets. |
120166-69-0 |
DC23017 |
R 59022
Featured
A small molecule inhibitor of diacylglycerol kinase (DGK) with IC50 of 2.8 uM, inhibits the phosphorylation of OAG to OAPA with IC50 of 3.8 uM in intact platelets. |
93076-89-2 |
DC24022 |
NSC-305787 hydrochloride
A small molecule inhibitor of Ezrin with Kd of 5.85 uM. |
53868-26-1 |
DC23826 |
UC-857993
A small molecule inhibitor of guanine nucleotide exchange factor (GEF) catalytic activity that binds to SOS1 (Kd=14.7 uM) and disrupts GEF-Ras interaction. |
487001-04-7 |
DC23810 |
UC-773587
A small molecule inhibitor of guanine nucleotide exchange factor (GEF) catalytic activity that binds to SOS1 (Kd=3.4 uM) and disrupts GEF-Ras interaction. |
116679-69-7 |
DC25040 |
Heclin
A small molecule inhibitor of HECT-type ubiquitin ligase with IC50 of 6.8/6.3/6.9 uM for Smurf2/Nedd4/WWP1, respectively. |
890605-54-6 |
DC22838 |
SCH 351125
A small molecule inhibitor of HIV-1 entry via the CCR5 coreceptor. |
370893-06-4 |
DC25031 |
C2-8
A small molecule inhibitor of polyglutamine (polyQ) aggregation in Huntington's disease neurons. |
300670-16-0 |
DC22761 |
NCI-83633
Featured
A small molecule inhibitor of PP2C that activates extensive 3' cleavage at a concentration 50-fold below that required by fluoride or CP.. |
732-85-4 |
DC22552 |
IC-87201
Featured
A small molecule inhibitor of PSD-95/nNOS interaction with IC50 of 31 uM, without inhibiting nNOS catalytic activity. |
866927-10-8 |
DC20360 |
DIDS
A small molecule inhibitor of RAD51-mediated homologous recombination. |
304655-84-3 |
DC25034 |
Lin28-IN-1632
A small molecule inhibitor of RNA binding protein Lin28 that blocks the Lin28/let-7 interaction, rescues let-7 processing and function in Lin28-expressing cancer cells. |
108825-65-6 |
DC23774 |
MS-444
A small molecule inhibitor of RNA-binding protein Hu protein R (HuR) that interferes the HuR homodimerization with Kd of 7 nM. |
150045-18-4 |
DC23773 |
Okicenone
A small molecule inhibitor of RNA-binding protein Hu protein R (HuR) that interferes the HuR homodimerization with Kd of 90 nM. |
137018-54-3 |
DC22852 |
Sortase-IN-6e
A small molecule inhibitor of Staphylococcus aureus sortase with IC50 of 9.3 uM. |
1809545-62-7 |
DC22984 |
IT-603
Featured
A small molecule inhibitor of the NF-κB family member c-Rel with IC50 of 3 uM in EMSA assays. |
292168-90-2 |
DC22833 |
KKL-35
Featured
A small molecule inhibitor of trans-translation that has broad-spectrum antibiotic activity. |
865285-29-6 |
DC21166 |
JK-273
A small molecule inhibitor of α4 integrin-dependent cell migration (IC50=0.5 uM, on the motility of Jurkat T cells) that functions by interacting with γ-parvin. |
187723-38-2 |
DC22832 |
Filastatin
Featured
Filastatin is a long-lasting inhibitor of Candida albicans filamentation. Filastatin inhibits adhesion by multiple pathogenic Candida species with an IC50 of ~3 μM in the GFP-based adhesion assay. Filastatin inhibits fungal adhesion to polystyrene and human cells, the yeast-to-hyphal morphological transition, induction of the hyphal-specific HWP1 promoter. Filastatin has potent antifungal effect. |
431996-53-1 |
DC23982 |
Navoximod (GDC-0919; NLG-919)
Featured
Navoximod (GDC-0919; NLG-919) is a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor with Ki/EC50 of 7 nM/75 nM. |
1402837-78-8 |
DC21415 |
Ferristatin II
A small molecule iron transport inhibitor that promotes degradation of transferrin receptor-1 in vitro and in vivo, through a nystatin-sensitive lipid raft pathway. |
1937-37-7 |
DC23314 |
UNC-2170 maleate
A small molecule ligand for the methyl-lysine binding protein 53BP1 (p53-binding protein 1) with Kd of 22 uM against the 53BP1 tandem tudor domain. |
2173992-60-2 |
DC20453 |
MitoBloCK 6
A small molecule mitochondrial protein import blocker that inhibits Erv1 oxidase activity. |
303215-67-0 |
DC21795 |
VJ115
A small molecule NADH oxidase ENOX1 inhibitor with IC50 of 10 uM. |
929256-79-1 |
DC23762 |
PDI inhibitor 16F16
Featured
PDI inhibitor 16F16 is a protein disulfide isomerase (PDI) inhibitor, first identified in a screen for compounds that prevent apoptosis induced by mutant huntingtin protein. 16F16 not only suppressed apoptosis induced by the misfolded protein mutant hungtingtin, it also protected rat neurons from cell death triggered by Aβ peptide. The actions of this inhibitor helped to identify a new mechanism in which a cell death pathway is regulated by protein misfolding via PDI upregulation. |
922507-80-0 |
DC21395 |
NPD926
A small molecule ROS inducer that induces rapid cell death in cancer cells, induces reactive oxygen species via cellular glutathione depletion. |
384361-79-9 |
DC23505 |
JVW-1009
A small molecule sigma receptor ligand with Ki of 96 and 70 nM for sigma 1 and sigma 2, respectively. |
2089059-30-1 |
DC23210 |
SZL P1-41
Featured
A small molecule Skp2 E3 ligase inhibitor that prevents Skp2-Skp1 interaction and Skp2 SCF E3 ligase activity in vitro. |
222716-34-9 |
DC20527 |
Ractopamine
Featured
A small molecule TAAR1 agonist and β adrenoreceptor agonist that stimulates β1 and β2 adrenergic receptors. |
97825-25-7 |